Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03808545 · ClinicalTrials.gov registry record · NA
Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS
A NA study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03808545 is a NA study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 11 participants.
The verdict
NCT03808545, a NA study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Multiple sclerosis (MS) is the leading cause of irreversible neurological disability among young women and the second leading cause of disability among young men in the U.S. Cardiometabolic risk factors including obesity and hyperlipidemia are common among people with MS, and these risk factors are associated with severity and frequency of MS relapses and disease progression. People with MS often experience symptoms of pain, fatigue, and depression, which make adhering to a healthy lifestyle difficult, as evidenced by the high rates of unhealthy behaviors including poor diet and physical inactivity among this group. Physical activity has reduced symptoms of MS and improved metabolic risk profiles, but little research has focused on the role of a dietary intervention combined with physical activity in this group. Therefore, the purpose of this study is to test the efficacy of a combined diet and physical activity intervention for reducing cardiometabolic risks and MS symptoms when compared to a physical activity intervention alone.
Interventions
- BEHAVIORAL Behavioral Intervention for Physical Activity in Multiple Sclerosis (BIPAMS)
- BEHAVIORAL BIPAMS + Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-02-26 |
| Est. Completion | 2020-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03808545
The ClinicalTrials.gov registry entry for NCT03808545 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral Intervention for Physical Activity in Multiple Sclerosis (BIPAMS) is the first listed.
NCT03808545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03808545 about?
NCT03808545 is a clinical study titled "Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS". Multiple sclerosis (MS) is the leading cause of irreversible neurological disability among young women and the second leading cause of disability among young men in the U.S. Cardiometabolic risk factors including obesity and hyperlipidemia are common among people with MS, and these risk factors are ...
What is the current status of trial NCT03808545?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2019-02-26. Estimated completion is 2020-03-19.
What interventions are being tested in trial NCT03808545?
The interventions under investigation include: Behavioral Intervention for Physical Activity in Multiple Sclerosis (BIPAMS) (BEHAVIORAL), BIPAMS + Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03808545?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.